Riskpilot← Back to searchSign inGet full accessSPZ LAB A/S
A/SActiveCVR 29769796Fruebjergvej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 20065 employees
Revenue 2025
DKK 1,4M
+47% vs 2024
EBITDA margin
12.6%
+106% vs 2024
Equity ratio
81.0%
Financial strength
Net profit 2025
DKK 105K
+193% vs 2024
| Revenue | DKK 1,4M | +47% |
| EBITDA | DKK 170K | +106% |
| Net profit | DKK 105K | +193% |
| Total assets | DKK 699K | +23% |
| Equity | DKK 567K | +23% |
| Employees | 5 | — |
Legal name
SPZ LAB A/S
CVR number
29769796
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. august 2006
Share capital
DKK 875.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af en direktør alene.
Company purpose
Selskabets formål er at drive virksomhed ved udførelse af bioteknologisk diagnostik, forskning og udvikling og dermed beslægtet virksomhed.
Address
Fruebjergvej 3
Phone
+4539179784
Email
pc@spz-lab.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 785 | 368 | 404 | 577 | 427 | 297 | 573 | 420 | 738 | 1.582 | 953 | 753 | 918 | 1.353 |
| Staff expenses | -565 | -423 | -143 | -406 | -297 | -228 | -441 | -271 | -583 | -998 | -1.154 | -921 | -836 | -1.183 |
| EBITDA | 220 | -56 | 261 | 170 | 130 | 69 | 132 | 148 | 155 | 585 | -201 | -168 | 83 | 170 |
| Depreciation & amort. | 52 | 30 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -9 | -23 | -27 | -27 | -27 |
| EBIT | 168 | -86 | 261 | 170 | 130 | 69 | 132 | 148 | 155 | 576 | -224 | -196 | 55 | 142 |
| Net financials | -101 | -111 | -108 | -80 | -71 | -58 | -42 | -4 | -4 | -11 | -10 | -4 | -7 | -11 |
| Profit before tax | 68 | -197 | 153 | 90 | 59 | 11 | 91 | 144 | 151 | 565 | -234 | -200 | 48 | 131 |
| Tax | -12 | -41 | 50 | 39 | 14 | 5 | 21 | 33 | 34 | 125 | -55 | -64 | 12 | 26 |
| Net profit | 80 | -156 | 102 | 51 | 46 | 6 | 70 | 111 | 117 | 440 | -179 | -137 | 36 | 105 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 540 | 401 | 354 | 313 | 402 | 425 | 507 | 367 | 457 | 1.007 | 674 | 575 | 567 | 699 |
| Equity | -296 | -453 | -350 | -299 | -253 | -247 | 73 | 184 | 301 | 741 | 562 | 425 | 461 | 567 |
| Long-term debt | 0 | 437 | 376 | 225 | 127 | 44 | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 836 | 416 | 329 | 387 | 529 | 628 | 387 | 183 | 155 | 265 | 112 | 150 | 106 | 132 |
| Total debt | 836 | 854 | 704 | 612 | 656 | 672 | 434 | 183 | 155 | 265 | 112 | 150 | 106 | 132 |
EBITDA margin
12.6%
This company
15.8%
Market median
-20% vs market
20122025
Equity ratio
81.0%
This company
38.2%
Market median
+112% vs market
20122025
Return on equity
18.6%
This company
18.4%
Market median
+1% vs market
20122025
Net profit margin
7.8%
This company
8.1%
Market median
-4% vs market
20122025
Asset turnover
1.94×
This company
1.12×
Market median
+73% vs market
20122025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PC Management | Management | 2006 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2006 | — | — | |
| Board of Directors | 2006 | — | — | |
| Chairman | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PREBEN CHRISTENSEN HOLDING ApS | Company | 66.7% | 66.7% | 2018 |
ANDERS BIRCK HOLDING ApS | Company | 10.0% | 10.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ANDERS BIRCK HOLDING ApS
SPZ LAB A/S Board members of SPZ LAB A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Preben Christensen | Management | 0 companies |
| Søren Leth-Nissen | Chairman | 0 companies |
| Anders Muusfeldt Birck | Board of Directors | 0 companies |
| Anders Ørgaard | Chairman | 0 companies |